WallStreetZenWallStreetZen

NASDAQ: AVDL
Avadel Pharmaceuticals PLC Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

AVDL past revenue growth

How has AVDL's revenue growth performed historically?
Company
6,260.23%
Industry
35.59%
Market
17.41%
AVDL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AVDL's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AVDL's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AVDL earnings and revenue history

Current Revenue
$95.1M
Current Earnings
-$106.2M
Current Profit Margin
-111.6%

AVDL Return on Equity

Current Company
-122.6%
Current Industry
10.2%
Current Market
33.8%
AVDL's Return on Equity (-122.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AVDL announces earnings.

AVDL Return on Assets

Current Company
-61.3%
Current Industry
3.6%
AVDL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AVDL Return on Capital Employed

Current Company
-85.92%
Current Industry
10.9%
AVDL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AVDL vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AVDL$95.15M-$95.46M-$106.22M+4.95%N/A
INDV$1.15B-$126.00M-$141.00M+14.36%N/A
EVON/AN/AN/A+99.41%N/A
ANIP$538.95M$118.65M$25.39M+20.17%-4.43%
COLL$576.65M$363.60M$99.89M+14.49%-14.87%
View Top Pharmaceutical Stocks

AVDL earnings dates

Next earnings date
Nov 6, 2024

Avadel Pharmaceuticals Earnings & Revenue FAQ

What were AVDL's earnings last quarter?

On Invalid Date, Avadel Pharmaceuticals (NASDAQ: AVDL) reported Q2 2024 earnings per share (EPS) of -$0.14, up 83.13% year over year. Total Avadel Pharmaceuticals earnings for the quarter were -$13.82 million. In the same quarter last year, Avadel Pharmaceuticals's earnings per share (EPS) was -$0.83.

If you're new to stock investing, here's how to buy Avadel Pharmaceuticals stock.

What was AVDL's earnings growth in the past year?

As of Q3 2024, Avadel Pharmaceuticals's earnings has grown year over year. Avadel Pharmaceuticals's earnings in the past year totalled -$106.22 million.

What is AVDL's earnings date?

Avadel Pharmaceuticals's earnings date is Invalid Date. Add AVDL to your watchlist to be reminded of AVDL's next earnings announcement.

What was AVDL's revenue last quarter?

On Invalid Date, Avadel Pharmaceuticals (NASDAQ: AVDL) reported Q2 2024 revenue of $41.50 million up 2,674.33% year over year. In the same quarter last year, Avadel Pharmaceuticals's revenue was $1.50 million.

What was AVDL's revenue growth in the past year?

As of Q3 2024, Avadel Pharmaceuticals's revenue has grown 6,260.23% year over year. This is 6,224.64 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 35.59%. Avadel Pharmaceuticals's revenue in the past year totalled $95.15 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.